Takara Bio USA unveils AACR benchmark data for Trekker FX, but will cancer labs switch?

Takara Bio USA says Trekker FX outperformed conventional spatial methods in a cancer benchmark study. Read what this could mean for oncology research.

Takara Bio USA says Trekker FX outperformed conventional spatial methods in a cancer benchmark study. Read what this could mean for oncology research.

Senhwa Biosciences and CellType partner to advance silmitasertib with AI. Discover how the collaboration could reshape immunotherapy research.

BD launches an AI-powered panel design tool for flow cytometry. Find out how it’s reshaping immunology and cancer research automation.